12th Annual Meeting of The Photomedicine Society

Thursday, March 20, 2003
Yerba Buena Salon 3-6, San Francisco Marriott, San Francisco, CA, USA

8:25-8:30 OPENING REMARKS (Yerba Buena Salon 3-6): Warwick L. Morison, M.D.

ORAL SESSION I (Yerba Buena Salon 3-6):

8:30-8:40 Abstract 10
Efficacy of topical white tea against UV-induced Langerhans cell depletion and DNA damage in human skin.. Baron ED, Swain FR, Matsui M, Marenus K, Maes D, Cooper KD, Stevens SR. University Hospitals of Cleveland/Case Western Reserve University, Cleveland, Ohio; and Estee Lauder Companies, Melville, New York, USA.

8:45-8:55 *Abstract 7
UV-free phototherapy: development and first clinical results. Medve-Koenigs D, Mahnke N, Ruzicka T, Ranft U, Wilkens JH, Krutmann J. Heinrich-Heine University, Duesseldorf, and OptoMed Group, Berlin/Wildau, Germany.

9:00-9:10 Abstract 14
The contributing chromophores to Amelanin@ pigmentation. Stamatas G, Kollias N. Johnson and Johnson Consumer Products Company, Skillman, New Jersey, USA.

9:15-9:25 Abstract 15
Synthetic and natural melanins exhibit specific measurable raman scattering activity. Huang Z, Zeng H, Chen MXK, McLean DI, Lui H. University of British Columbia, BC Cancer Agency, Simon Fraser University, Vancouver, British Columbia, Canada.

9:30-9:40 Abstract 9
Prevention of UV-induced immune suppression on humans by T4 liposomes, RNA and a multiagent lotion. Baron ED, Swain FR, Matsui M, Marenus K, Maes D, Cooper KD, Stevens SR. University Hospitals of Cleveland/Case Western Reserve University, Cleveland, Ohio; and Estee Lauder Companies, Melville, New York, USA.

9:45-9:55 Abstract 13
An important role of B7/CTLA-4 signaling in the development of murine UV-induced skin tumors. Beissert S, Bluestone A, Sharpe AH, Voskort M, Scherer A, Schwarz T. University of Münster, Münster, Germany; The University of California San Francisco, San Francisco, California; and Harvard University, Boston, Massachusetts, USA.

10:00-10:20 BREAK FOR COFFEE AND POSTER VIEWING (Grand Salon 7)

SPECIAL TOPICS (Yerba Buena Salons 3-6)

10:20-11:20 UV induced oxidation in the skin. Moderated by Thomas Schwarz, M.D.
11:30-12:30 GUEST SPEAKER: R. Rox Anderson, M.D. "Stalking the wild blood vessel."

12:30-2:00 LUNCH AND POSTER VIEWING

(Board of Directors meeting at lunch)

ORAL SESSION III (Yerba Buena Salons 3-6)

2:00-2:10 Abstract 1
Increased 298-303 nanometer wavelengths and skin cancer under the Antarctic ozone hole: Southern Chile.. Abarca J, Casiccia C. Hospital and University of Magallanes, Punta Arenas, Chile.

2:15-2:25 Abstract 11
Narrow band UVB is effective in paediatric patients of vitiligo. Handa S, Dogra S, Kanwar AJ. Postgraduate Institute of Medical Education & Research, Chandigarh, India.

2:30-2:40 Abstract 16
Lupus erythematosus tumidus. Kuhn A, Lehmann P, Ruzicka T. University of Duesseldorf, University of Witten-Herdecke, Duesseldorf, Germany.

2:45-2:55 Abstract 12
Treatment of oral graft versus host disease with psoralens and visible light. Hamzavi IH, Truong S, Hamzavi FH, Murakwa G. Wayne State University, Detroit, Michigan, USA.

3:00-3:10 Abstract 8
Treatment of vitiligo with narrow-band UVB and KUVA: results of two intraindividual comparison studies. Stege H, Medve-Koenigs K, Mahnke N, Ruzicka T, Neumann N, Krutmann J. Heinrich-Heine University, Duesseldorf, Germany.

3:15-3:25 Abstract 17
Regulation of keratinocyte SNF1/AMPK related kinase (SNARK) activity by cellular stressors. Lefebvre DL, Drucker DJ, Song L, Rosen CF. University of Toronto, Toronto, Canada.

SPECIAL TOPICS (Yerba Buena Salons 3-6)

3:40-4:40 Antioxidants and the skin. Moderated by Sheldon Pinnell, M.D.

4:40-5:00 POSTER DISCUSSION: (Yerba Buena Salons 3-6) Moderated by Michael Zanolli, MD

Abstract 2
Ultraviolet radiation doses of Mexican school children. Castanedo-Cazares JP, Lepe V, Gordillo- Moscoso A, Moncada B. Universidad Autonoma de San Luis Potosí, San Luis Potosí, Mexico.

Abstract 3
Phototherapy: Evaluation of the treatment for several dermatosis between two clinics of phototherapy. Duarte I, Buense R, Lazzarini R. Sao Paulo, Brazil.

Abstract 4
The optimal number of irradiations in diagnostic photoprovocation tests.. Schornagel IJ, Guikers CLH, Appelman A, van Weelden H, Sybesma I, Bruijnzeel-Koomen CAFM, Sigurdsson V. University Medical Center Utrecht, Utrecht, The Netherlands.

*Abstract 5
Evaluation of a targeted UVB phototherapy device for the treatment of vitiligo. Kerr HA, Kontos AP, Lim HW. Henry Ford Health System, Detroit, Michigan, USA.

Abstract 6
Protection against ultraviolet radiation-induced cutaneous inflammation with olivenolJ in hairless mice. Sambuco CP, Arocena MA, D=Aloisio LC, Learn DB, Forbes PD, Hoberman AM, Crea R. Charles River Laboratories, Horsham, Pennsylvania; CreAgri, Inc., Hayward, Calfornia, USA.

Abstract 18
A case of dacarbazine-induced photosensitivity. Fukuchi O, Ishikawa M, Inoue M, Kamide R. The Jikei University School of Medicine, Tokyo, Japan.

30-8:00 COCKTAIL/RECEPTION: In conjunction with the American Contact Dermatitis Society Qualifies for Best Presentation award by resident/fellow/student.